Riskpilot← Back to searchSign inGet full accessEFARMA AS
ASActiveOrg 917338809Ringvålvegen 15A, 7080 HeimdalNon-specialised wholesale of food, beverages and tobacco · NACE 4639Est. 20160 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
NOK -20K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK -20K | — |
| Net profit | NOK -20K | — |
| Total assets | NOK 0 | -100% |
| Equity | NOK -120K | -20% |
| Employees | 0 | — |
Legal name
EFARMA AS
Org number
917338809
Legal form
Aksjeselskap
NACE code
4639 · Non-specialised wholesale of food, beverages and tobacco
Founded
29. juni 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Import og handelsvirksomhet med produkter knyttet til omsorgs-/hygieneartikler, næringsmidler, helsekost, skjønnhetspleie samt hva hermed står i naturlig forbindelse.
Address
Ringvålvegen 15A, 7080 Heimdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −5 | 0 | −10 | 0 | −20 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | 0 | −10 | 0 | −20 |
| Net financials | −0 | 0 | 0 | 0 | 0 |
| Profit before tax | −5 | 0 | −10 | 0 | −20 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −5 | 0 | −10 | 0 | −20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 30 | 20 | 20 | 0 |
| Equity | −90 | −90 | −100 | −100 | −120 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 120 | 120 | 120 | 120 | 120 |
| Total debt | 120 | 120 | 120 | 120 | 120 |
EBITDA margin
-2000000.0%
This company
15.8%
Market median
-12658328% vs market
20202024
Equity ratio
-12015100.0%
This company
38.2%
Market median
-31453241% vs market
20202024
Return on equity
-2000000.0%
This company
18.4%
Market median
-10869665% vs market
20202024
Net profit margin
-2000000.0%
This company
8.1%
Market median
-24691458% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RH Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Aura Meidute | Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EFARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Henning Eriksen | Chief Executive Officer | 0 companies |
| Rune Vilhelmsen | Chairman | 0 companies |
| Rasa Vilhelmsen | Board of Directors | 0 companies |